Ina-Maria Rudolph
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ina-Maria Rudolph has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Sebastian Diecke
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Technology Platform Pluripotent Stem Cells, Berlin, Germany
2 shared publications - Thomas E. Willnow
Department of Biomedicine Aarhus University Aarhus Denmark
2 shared publications Anna K. Greda
Department of Biomedicine, Aarhus University, Aarhus, Denmark
1 shared publicationCagla Cömert
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
1 shared publication- Duncan Stewart Sutherland
Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Gustav Wieds Vej 14, 8000 Aarhus, Denmark
1 shared publication Ewa Zurawska-Plaksej
Molecular Cardiovascular Research, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
1 shared publication
Latest Publications
- Open Access
- 16 October 2025
- Published by Springer Nature in Nature Metabolism
- Vol. 7 (11) , 2346-2365
Interaction of sortilin with apolipoprotein E3 enables neurons to use long-chain fatty acids as alternative metabolic fuel
Sortilin (SORT1) is a lipoprotein receptor that shows genome-wide association with hypercholesterolaemia, explained by its ability to control hepatic output of lipoproteins. Although SORT1 also shows genome-wide association with Alzheimer disease and frontotemporal lobe dementia, the most prevalent forms of age-related dementias, sortilin’s contribution to human brain lipid metabolism and health remains unclear. Here we show that sortilin mediates neuronal uptake of polyunsaturated fatty acids carried by apolipoprotein E (apoE). Using humanized mouse strains and induced pluripotent stem cell-based cell models of brain lipid homeostasis, we demonstrate that internalized lipids are converted into ligands for peroxisome proliferator-activated receptor alpha inducing transcription profiles that enable neurons to use long-chain fatty acids as metabolic fuel when glucose is limited. This pathway works with apoE3 but cannot operate with the Alzheimer disease risk factor apoE4, which disrupts sortilin’s endocytic activity. Our data indicate a role for the lipoprotein receptor sortilin in metabolic fuel choice in neurons, which may be crucial when glucose supply is limited, such as in the ageing brain.
- 16 October 2025
- Published by Springer Nature in Nature Metabolism
- Vol. 7 (11) , 2346-2365
Open AccessInteraction of sortilin with apolipoprotein E3 enables neurons to use long-chain fatty acids as alternative metabolic fuel
Sortilin (SORT1) is a lipoprotein receptor that shows genome-wide association with hypercholesterolaemia, explained by its ability to control hepatic output of lipoproteins. Although SORT1 also shows genome-wide association with Alzheimer disease and frontotemporal lobe dementia, the most prevalent forms of age-related dementias, sortilin’s contribution to human brain lipid metabolism and health remains unclear. Here we show that sortilin mediates neuronal uptake of polyunsaturated fatty acids carried by apolipoprotein E (apoE). Using humanized mouse strains and induced pluripotent stem cell-based cell models of brain lipid homeostasis, we demonstrate that internalized lipids are converted into ligands for peroxisome proliferator-activated receptor alpha inducing transcription profiles that enable neurons to use long-chain fatty acids as metabolic fuel when glucose is limited. This pathway works with apoE3 but cannot operate with the Alzheimer disease risk factor apoE4, which disrupts sortilin’s endocytic activity. Our data indicate a role for the lipoprotein receptor sortilin in metabolic fuel choice in neurons, which may be crucial when glucose supply is limited, such as in the ageing brain.
- Open Access
- 10 September 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (9) , e70591
Familial Alzheimer's disease mutation identifies novel role of SORLA in release of neurotrophic exosomes
INTRODUCTION: Mutations in SORL1 , encoding the sorting receptor Sortilin‐related receptor with A‐type repeats (SORLA), are found in individuals with Alzheimer's disease (AD). We studied SORLA N1358S , carrying a mutation in its ligand binding domain, to learn more about receptor functions relevant for human brain health. METHODS: We investigated consequences of SORLA N1358S expression in induced pluripotent stem cell (iPSC)‐derived human neurons and microglia, using unbiased proteome screens and functional cell assays. RESULTS: We identified alterations in the SORLA N1358S interactome linked to biogenesis of exosomes. Consequently, the mutant receptor failed to promote release and neurotrophic qualities of exosomes, a defect attributed to altered exosomal content of microRNAs controlling neuronal maturation. DISCUSSION: We identified a role for SORLA in controlling quantity and neurotrophic quality of exosomes secreted by cells, suggesting impaired cellular cross talk through exosomes as a pathological trait contributing to AD pathology in carriers of SORL1 variants. Highlights: Familial Alzheimer's disease mutation in SORL1 changes interactome of mutant Sortilin‐related receptor with A‐type repeats (SORLA). Mutant SORLA impairs release of exosomes from neurons and microglia. Mutant exosomes lack neurotrophic qualities. Defect linked to alterations in microRNA content.
- 10 September 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (9) , e70591
Open AccessFamilial Alzheimer's disease mutation identifies novel role of SORLA in release of neurotrophic exosomes
INTRODUCTION: Mutations in SORL1 , encoding the sorting receptor Sortilin‐related receptor with A‐type repeats (SORLA), are found in individuals with Alzheimer's disease (AD). We studied SORLA N1358S , carrying a mutation in its ligand binding domain, to learn more about receptor functions relevant for human brain health. METHODS: We investigated consequences of SORLA N1358S expression in induced pluripotent stem cell (iPSC)‐derived human neurons and microglia, using unbiased proteome screens and functional cell assays. RESULTS: We identified alterations in the SORLA N1358S interactome linked to biogenesis of exosomes. Consequently, the mutant receptor failed to promote release and neurotrophic qualities of exosomes, a defect attributed to altered exosomal content of microRNAs controlling neuronal maturation. DISCUSSION: We identified a role for SORLA in controlling quantity and neurotrophic quality of exosomes secreted by cells, suggesting impaired cellular cross talk through exosomes as a pathological trait contributing to AD pathology in carriers of SORL1 variants. Highlights: Familial Alzheimer's disease mutation in SORL1 changes interactome of mutant Sortilin‐related receptor with A‐type repeats (SORLA). Mutant SORLA impairs release of exosomes from neurons and microglia. Mutant exosomes lack neurotrophic qualities. Defect linked to alterations in microRNA content.